PDF(Pubmed)
Abstract：
Atypical fractures are gaining attention as a severe potential side effect of long-term treatment with bone-modifying agents (e.g., bisphosphonate and denosumab) for osteoporosis. Most atypical fractures occur in weight-bearing bones; the femur is the most frequent site. Atypical fractures occurring in non-weight-bearing bones are extremely rare. We describe an atypical fracture of the scapular spine in a 92-year-old Japanese woman with osteoporosis who had been treated with minodronate for ~7 years. Although the dislocation of the fracture site remained after conservative treatment, there was no obstacle to her daily life.
摘要：
非典型骨折作为长期使用骨改性剂治疗的严重潜在副作用而引起人们的注意（例如，双膦酸盐和denosumab）用于骨质疏松症。大多数非典型骨折发生在负重骨；股骨是最常见的部位。非负重骨骼中发生的非典型骨折极为罕见。我们描述了一名92岁的日本骨质疏松症女性的肩胛骨脊柱非典型骨折，该女性接受了米诺膦酸盐治疗约7年。虽然保守治疗后骨折部位仍有脱位,她的日常生活没有障碍。
